Literature DB >> 26871923

Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.

J Wan1, J M Gelfand1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26871923      PMCID： PMC5290477          DOI： 10.1111/bjd.14304

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

1.  Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Authors:  N M Seminara; K Abuabara; D B Shin; S M Langan; S E Kimmel; D Margolis; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2011-02-03       Impact factor: 9.302

2.  British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.

Authors:  C H Smith; A V Anstey; J N W N Barker; A D Burden; R J G Chalmers; D Chandler; A Y Finlay; C E M Griffiths; C E M Grifitths; K Jackson; N J McHugh; K E McKenna; N J Reynolds; A D Ormerod
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

3.  British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

Authors:  C H Smith; A V Anstey; J N W N Barker; A D Burden; R J G Chalmers; D A Chandler; A Y Finlay; C E M Griffiths; K Jackson; N J McHugh; K E McKenna; N J Reynolds; A D Ormerod
Journal:  Br J Dermatol       Date:  2009-11       Impact factor: 9.302

4.  Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study.

Authors:  Ching-Chi Chi; Jui Wang; Yu-Fen Chen; Shu-Hui Wang; Fu-Li Chen; Tao-Hsin Tung
Journal:  J Dermatol Sci       Date:  2015-03-30       Impact factor: 4.563

5.  Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.

Authors:  G J Nevitt; P E Hutchinson
Journal:  Br J Dermatol       Date:  1996-10       Impact factor: 9.302

6.  Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.

Authors:  H-Y Chiu; H-L Huang; C-H Li; Y-J Yin; H-A Chen; S-T Hsu; S-J Lin; T-F Tsai; S-Y Ho
Journal:  Br J Dermatol       Date:  2015-05-12       Impact factor: 9.302

7.  Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.

Authors:  Junko Takeshita; Shuwei Wang; Daniel B Shin; Nehal N Mehta; Stephen E Kimmel; David J Margolis; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

8.  Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.

Authors:  Axel Svedbom; Johan Dalén; Carla Mamolo; Joseph C Cappelleri; Lotus Mallbris; Ingemar F Petersson; Mona Ståhle
Journal:  Acta Derm Venereol       Date:  2015-09       Impact factor: 4.437

9.  Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Authors:  Joy Wan; Shuwei Wang; Kevin Haynes; Michelle R Denburg; Daniel B Shin; Joel M Gelfand
Journal:  BMJ       Date:  2013-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.